# Baxter Healthcare Corporation – FDA Inspection, Oct 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c1d10e56-429e-4824-ad25-8e7620b75c8b
Source feed: FDA_Inspections

> FDA inspection 1069929 of Baxter Healthcare Corporation, October 24, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069929
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2018-10-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1264998 - 2025-03-26](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c166157d-0966-4c68-93e0-ef3356642ba0)
- FDA Inspection 1130593 - 2020-09-16
- FDA Inspection 1000845 - 2016-12-13
- FDA Inspection 913366 - 2015-02-06
- FDA Inspection 863409 - 2013-12-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/511e2b34-f9c9-4059-b74d-d1cd59ed6678

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c